IMCD reports 17% EBITA growth in the first nine months of 2016

Aug 23, 2016

ROTTERDAM, The Netherlands

IMCD reports 26% EBITA growth in the first half of 2016

IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and food ingredients, today announces its first half year 2016 results.

Highlights

Gross profit growth of 20% to EUR 194.0 million (+25% on a constant currency basis)
Operating EBITA increase of 26% to EUR 78.3 million (+31% on a constant currency basis)
Net result before amortisation and non-recurring items increase of 28% to EUR 54.0 million (+31% on a constant currency basis)
Cash earnings per share increased by 25% to EUR 1.01
Acquisition of Mutchler, completed on 1 July 2016, expanding the US operations into the pharmaceutical market

Piet van der Slikke, CEO: 'We are satisfied with our results in the first half of 2016. Our business has shown growth both as a result of the acquisitions in the US and Brazil in 2015 and organically. The recent acquisition of Mutchler in the US and Puerto Rico is an important further step in the execution of our US strategy and our global strategy in pharmaceuticals. In an increasingly uncertain macro-economic environment we continue to focus on executing our strategy and on operational excellence.'

To read the full press release, please click the link below:

PRESS RELEASE - IMCD First half year 2016 results